Skip to main content
Caplight Logo









Procyrion

Procyrion

Private
Houston, TexasHealthcare & Life Scienceshttps://www.procyrion.com/

Last Round

Series E

Feb 5, 2024

Total Funding Raised

$114.5M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Procyrion is a medical device company that develops percutaneous mechanical circulatory support technology for patients with cardiac and renal impairment.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

mechanical circulatory supportMCSheart pumppercutaneous supporthemodynamic supportheart failure treatmentcatheter-deployed deviceaxial-flow pumpcardiovascular medical deviceinterventional cardiologyminimally invasive cardiologymedtechmedical device reimbursement

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Procyrion Comparables

Compare Procyrion with similar companies based on industry and business-model similarity.

Procyrion comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Puzzle Medical Devices Inc.
90%
Supira Medical
87%
Magenta Medical
86%

Procyrion Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series EFeb 5, 2024
Series DJul 9, 2019
Series CJan 30, 2018
Series BOct 9, 2015
GrantJul 15, 2014
Corporate Funding
Jan 14, 2014

Key People

Founding team and executive leadership

Eric Fain

President And CEO

Executive Team

Procyrion Investors

Notable investors and investment history

Procyrion investors
InvestorRounds
Scientific Health DevelopmentSeries B, Series D, Series C
Fannin Innovation StudioSeries B, Series D, Series C, Series E, Seed
Bluebird VenturesSeries E, Series D
National Capital Consortium for Pediatric Device InnovationGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 19, 2026

    Grew 16% QoQ from 25 to 29 employees.

  • Jul 24, 2026

    Monthly visitors grew 32% MoM.

Procyrion Filings

Explore SEC and related filing metadata, where available.

Procyrion filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Procyrion's valuation, stock price, and market status.

Is Procyrion a public or private company?

Procyrion is a private company.

What is the current stock price of Procyrion?

Procyrion is a private company with no public stock price. No recent secondary market data is available.

How much is Procyrion worth (valuation)?

Valuation information for Procyrion is not publicly available.

Can I buy Procyrion stock?

Procyrion shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Procyrion's last funding round?

Procyrion's most recent funding round was Series E on February 5, 2024.

Who are the main investors in Procyrion?

Key investors in Procyrion include Fannin Innovation Studio, Bluebird Ventures.

Will Procyrion IPO soon?

No public IPO plans have been announced for Procyrion.

How can I track Procyrion secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Procyrion's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHouston, Texas
Employee Range20
Year Founded2005
Last FundingFeb 5, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?